157 related articles for article (PubMed ID: 30674342)
1. Enhanced phosphorylation of T153 in soluble tau is a defining biochemical feature of the A152T tau risk variant.
Carlomagno Y; Chung DC; Yue M; Kurti A; Avendano NM; Castanedes-Casey M; Hinkle KM; Jansen-West K; Daughrity LM; Tong J; Phillips V; Rademakers R; DeTure M; Fryer JD; Dickson DW; Petrucelli L; Cook C
Acta Neuropathol Commun; 2019 Jan; 7(1):10. PubMed ID: 30674342
[TBL] [Abstract][Full Text] [Related]
2. Tau mutant A152T, a risk factor for FTD/PSP, induces neuronal dysfunction and reduced lifespan independently of aggregation in a C. elegans Tauopathy model.
Pir GJ; Choudhary B; Mandelkow E; Mandelkow EM
Mol Neurodegener; 2016 Apr; 11():33. PubMed ID: 27118310
[TBL] [Abstract][Full Text] [Related]
3. Tau/MAPT disease-associated variant A152T alters tau function and toxicity via impaired retrograde axonal transport.
Butler VJ; Salazar DA; Soriano-Castell D; Alves-Ferreira M; Dennissen FJA; Vohra M; Oses-Prieto JA; Li KH; Wang AL; Jing B; Li B; Groisman A; Gutierrez E; Mooney S; Burlingame AL; Ashrafi K; Mandelkow EM; Encalada SE; Kao AW
Hum Mol Genet; 2019 May; 28(9):1498-1514. PubMed ID: 30590647
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.
Coppola G; Chinnathambi S; Lee JJ; Dombroski BA; Baker MC; Soto-Ortolaza AI; Lee SE; Klein E; Huang AY; Sears R; Lane JR; Karydas AM; Kenet RO; Biernat J; Wang LS; Cotman CW; Decarli CS; Levey AI; Ringman JM; Mendez MF; Chui HC; Le Ber I; Brice A; Lupton MK; Preza E; Lovestone S; Powell J; Graff-Radford N; Petersen RC; Boeve BF; Lippa CF; Bigio EH; Mackenzie I; Finger E; Kertesz A; Caselli RJ; Gearing M; Juncos JL; Ghetti B; Spina S; Bordelon YM; Tourtellotte WW; Frosch MP; Vonsattel JP; Zarow C; Beach TG; Albin RL; Lieberman AP; Lee VM; Trojanowski JQ; Van Deerlin VM; Bird TD; Galasko DR; Masliah E; White CL; Troncoso JC; Hannequin D; Boxer AL; Geschwind MD; Kumar S; Mandelkow EM; Wszolek ZK; Uitti RJ; Dickson DW; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; ; Ross OA; Rademakers R; Schellenberg GD; Miller BL; Mandelkow E; Geschwind DH
Hum Mol Genet; 2012 Aug; 21(15):3500-12. PubMed ID: 22556362
[TBL] [Abstract][Full Text] [Related]
5. Expression of A152T human tau causes age-dependent neuronal dysfunction and loss in transgenic mice.
Maeda S; Djukic B; Taneja P; Yu GQ; Lo I; Davis A; Craft R; Guo W; Wang X; Kim D; Ponnusamy R; Gill TM; Masliah E; Mucke L
EMBO Rep; 2016 Apr; 17(4):530-51. PubMed ID: 26931567
[TBL] [Abstract][Full Text] [Related]
6. A152T tau allele causes neurodegeneration that can be ameliorated in a zebrafish model by autophagy induction.
Lopez A; Lee SE; Wojta K; Ramos EM; Klein E; Chen J; Boxer AL; Gorno-Tempini ML; Geschwind DH; Schlotawa L; Ogryzko NV; Bigio EH; Rogalski E; Weintraub S; Mesulam MM; ; Fleming A; Coppola G; Miller BL; Rubinsztein DC
Brain; 2017 Apr; 140(4):1128-1146. PubMed ID: 28334843
[TBL] [Abstract][Full Text] [Related]
7. The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features.
Kara E; Ling H; Pittman AM; Shaw K; de Silva R; Simone R; Holton JL; Warren JD; Rohrer JD; Xiromerisiou G; Lees A; Hardy J; Houlden H; Revesz T
Neurobiol Aging; 2012 Sep; 33(9):2231.e7-2231.e14. PubMed ID: 22595371
[TBL] [Abstract][Full Text] [Related]
8. Cre-inducible Adeno Associated Virus-mediated Expression of P301L Mutant Tau Causes Motor Deficits and Neuronal Degeneration in the Substantia Nigra.
You Y; Botros MB; Enoo AAV; Bockmiller A; Herron S; Delpech JC; Ikezu T
Neuroscience; 2019 Dec; 422():65-74. PubMed ID: 31689387
[TBL] [Abstract][Full Text] [Related]
9. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
10. Neuronal levels and sequence of tau modulate the power of brain rhythms.
Das M; Maeda S; Hu B; Yu GQ; Guo W; Lopez I; Yu X; Tai C; Wang X; Mucke L
Neurobiol Dis; 2018 Sep; 117():181-188. PubMed ID: 29859869
[TBL] [Abstract][Full Text] [Related]
11. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
Katsuse O; Iseki E; Arai T; Akiyama H; Togo T; Uchikado H; Kato M; de Silva R; Lees A; Kosaka K
Acta Neuropathol; 2003 Sep; 106(3):251-60. PubMed ID: 12802605
[TBL] [Abstract][Full Text] [Related]
12. Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration.
Gentry EG; Henderson BW; Arrant AE; Gearing M; Feng Y; Riddle NC; Herskowitz JH
J Neurosci; 2016 Jan; 36(4):1316-23. PubMed ID: 26818518
[TBL] [Abstract][Full Text] [Related]
13. Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease.
Lee SE; Tartaglia MC; Yener G; Genç S; Seeley WW; Sanchez-Juan P; Moreno F; Mendez MF; Klein E; Rademakers R; López de Munain A; Combarros O; Kramer JH; Kenet RO; Boxer AL; Geschwind MD; Gorno-Tempini ML; Karydas AM; Rabinovici GD; Coppola G; Geschwind DH; Miller BL
Alzheimer Dis Assoc Disord; 2013; 27(4):302-9. PubMed ID: 23518664
[TBL] [Abstract][Full Text] [Related]
14. Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy.
Koller EJ; Gonzalez De La Cruz E; Machula T; Ibanez KR; Lin WL; Williams T; Riffe CJ; Ryu D; Strang KH; Liu X; Janus C; Golde TE; Dickson D; Giasson BI; Chakrabarty P
Hum Mol Genet; 2019 Oct; 28(19):3255-3269. PubMed ID: 31261380
[TBL] [Abstract][Full Text] [Related]
15. Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy.
Piras A; Collin L; Grüninger F; Graff C; Rönnbäck A
Acta Neuropathol Commun; 2016 Mar; 4():22. PubMed ID: 26936765
[TBL] [Abstract][Full Text] [Related]
16. Upper airway dysfunction of Tau-P301L mice correlates with tauopathy in midbrain and ponto-medullary brainstem nuclei.
Dutschmann M; Menuet C; Stettner GM; Gestreau C; Borghgraef P; Devijver H; Gielis L; Hilaire G; Van Leuven F
J Neurosci; 2010 Feb; 30(5):1810-21. PubMed ID: 20130190
[TBL] [Abstract][Full Text] [Related]
17. The unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: Clinical and pathological characteristics.
Moreno F; Indakoetxea B; Barandiaran M; Caballero MC; Gorostidi A; Calafell F; Gabilondo A; Tainta M; Zulaica M; Martí Massó JF; López de Munain A; Sánchez-Juan P; Lee SE
PLoS One; 2017; 12(6):e0178093. PubMed ID: 28594853
[TBL] [Abstract][Full Text] [Related]
18. DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders.
Kumaran R; Kingsbury A; Coulter I; Lashley T; Williams D; de Silva R; Mann D; Revesz T; Lees A; Bandopadhyay R
Neurobiol Dis; 2007 Oct; 28(1):122-32. PubMed ID: 17719794
[TBL] [Abstract][Full Text] [Related]
19. Tau exhibits unique seeding properties in globular glial tauopathy.
Chung DC; Carlomagno Y; Cook CN; Jansen-West K; Daughrity L; Lewis-Tuffin LJ; Castanedes-Casey M; DeTure M; Dickson DW; Petrucelli L
Acta Neuropathol Commun; 2019 Mar; 7(1):36. PubMed ID: 30845985
[TBL] [Abstract][Full Text] [Related]
20. Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model.
Cook C; Kang SS; Carlomagno Y; Lin WL; Yue M; Kurti A; Shinohara M; Jansen-West K; Perkerson E; Castanedes-Casey M; Rousseau L; Phillips V; Bu G; Dickson DW; Petrucelli L; Fryer JD
Hum Mol Genet; 2015 Nov; 24(21):6198-212. PubMed ID: 26276810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
